Ferguson Wellman Capital Management Inc. Has $65.10 Million Stock Position in Stryker Co. (NYSE:SYK)

Ferguson Wellman Capital Management Inc. boosted its holdings in shares of Stryker Co. (NYSE:SYK - Free Report) by 1.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 174,871 shares of the medical technology company's stock after purchasing an additional 3,341 shares during the period. Stryker comprises 1.3% of Ferguson Wellman Capital Management Inc.'s portfolio, making the stock its 24th biggest holding. Ferguson Wellman Capital Management Inc.'s holdings in Stryker were worth $65,096,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Elefante Mark B acquired a new position in shares of Stryker in the 4th quarter worth approximately $337,000. Harbor Capital Advisors Inc. acquired a new position in shares of Stryker in the 1st quarter worth approximately $1,840,000. Metis Global Partners LLC boosted its holdings in shares of Stryker by 10.2% in the 4th quarter. Metis Global Partners LLC now owns 16,841 shares of the medical technology company's stock worth $6,064,000 after acquiring an additional 1,561 shares in the last quarter. Fred Alger Management LLC boosted its holdings in shares of Stryker by 415.8% in the 4th quarter. Fred Alger Management LLC now owns 24,011 shares of the medical technology company's stock worth $8,664,000 after acquiring an additional 19,356 shares in the last quarter. Finally, US Bancorp DE boosted its holdings in shares of Stryker by 0.5% in the 4th quarter. US Bancorp DE now owns 182,825 shares of the medical technology company's stock worth $65,829,000 after acquiring an additional 976 shares in the last quarter. Institutional investors own 77.09% of the company's stock.

Insider Transactions at Stryker

In related news, Director Ronda E. Stryker sold 200,000 shares of the firm's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the sale, the director now directly owns 3,417,326 shares in the company, valued at approximately $1,288,195,208.96. This trade represents a 5.53% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 5.90% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently commented on SYK shares. Roth Mkm boosted their target price on Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a report on Friday, May 2nd. Evercore ISI reduced their target price on Stryker from $400.00 to $390.00 and set an "outperform" rating on the stock in a report on Friday, May 2nd. JMP Securities reaffirmed a "market perform" rating on shares of Stryker in a report on Monday, May 5th. Sanford C. Bernstein set a $450.00 price objective on Stryker in a report on Monday, May 5th. Finally, Citigroup reaffirmed a "buy" rating and set a $455.00 price objective (up previously from $443.00) on shares of Stryker in a report on Thursday, May 22nd. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $427.30.

Stryker Stock Down 0.2%

SYK stock traded down $0.65 during trading hours on Thursday, reaching $380.43. 877,833 shares of the stock were exchanged, compared to its average volume of 1,330,801. The firm's 50-day moving average is $371.23 and its 200-day moving average is $375.95. The company has a market cap of $145.21 billion, a price-to-earnings ratio of 49.02, a PEG ratio of 2.93 and a beta of 0.91. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. Stryker Co. has a 12 month low of $314.93 and a 12 month high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last released its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. The firm had revenue of $5.87 billion during the quarter, compared to analysts' expectations of $5.68 billion. Stryker had a return on equity of 23.58% and a net margin of 13.25%. The company's revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.50 EPS. On average, equities research analysts expect that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be paid a dividend of $0.84 per share. The ex-dividend date is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.88%. Stryker's dividend payout ratio is 45.41%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.